Change in number of shares and votes in Aerocrine

  Change in number of shares and votes in Aerocrine

Business Wire

SOLNA, Sweden -- October 31, 2012

Regulatory News:

With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med
finansiella instrument” it’s hereby announced that through the subscription by
exercise of options in Aerocrine the number of shares and votes in Aerocrine
has increased during August 2012 as specified in the table below.

                   Number of shares and votes
August 1, 2012        144 947 999
Increase              299 510
August 31, 2012       145 247 509

Solna October 31, 2012

Aerocrine AB (publ.)

About Aerocrine

Aerocrine AB (STO:AERO-B) is a medical technology company focused on the
improved management and care of patients with inflammatory airway diseases.
The pioneer and leader in the technology to monitor and manage airway
inflammation, Aerocrine markets NIOX MINO® and NIOX® Flex. Both products
enable the fast and reliable measurement of airway inflammation and may thus
play a critical role in more effective diagnosis, treatment and follow-up of
patients with inflammatory airway diseases such as asthma. Aerocrine is based
in Sweden with subsidiaries in the US, Germany and the UK. Aerocrine shares
were listed on the Stockholm Stock Exchange on 15 June 2007.


Aerocrine may be required to disclose the information provided herein pursuant
to the Securities Markets Act and/or the Financial Instruments Trading Act.
The information was submitted for publication at 08:00 am on October 31, 2012.


This information was brought to you by Cision


Michael Colérus, CFO, +46 8 629 07 85
Press spacebar to pause and continue. Press esc to stop.